Higher-level gait disorders
There are 3 papers on higher-level gait disorders in aging research: 1 trial and 2 observational studies in people.
3 papers study it1 more mentions it5 findings
“HLGD had more depressive symptoms than non-neurological GD and no GD (GDS-15 HLGD, 3.9±3.4; non-neurological GD, 2.5±2.8; no GD, 1.4±2.0; p<0.05)”
- Human trial1
- Humans2
Effects
1Gait performance
downin humans1
1 study
Gait performance
downin humans1
Higher-level gait disorders are linked with worse gait performance in humans (compared to controls).
“Compared to controls, those with gait disorders exhibited worse cognitive and gait performance.”
Humanscompared to controlsn = 60
Gait & posture
Associations
4Balance confidence
downin humans1
1 study
Balance confidence
downin humans1
Higher-level gait disorders are associated with balance confidence in humans (FES(S) HLGD, 93±32; non-neurological GD, 111±25; no GD, 124±13; p<0.001).
“lower balance confidence (FES(S) HLGD, 93±32; non-neurological GD, 111±25; no GD, 124±13; p<0.001)”
Humans
BMJ neurology open
Gait confidence
downin humans1
1 study
Gait confidence
downin humans1
Higher-level gait disorders are associated with gait confidence in humans (mGES HLGD, 60±22; non-neurological GD, 74±21; no GD, 90±13; p<0.001).
“lower gait confidence (mGES HLGD, 60±22; non-neurological GD, 74±21; no GD, 90±13; p<0.001)”
Humans
BMJ neurology open
Quality of life
downin humans1
1 study
Quality of life
downin humans1
Higher-level gait disorders are associated with quality of life in humans (HLGD, 63±17; non-neurological GD, 71±18; no GD, 82±14; p<0.001).
“lower EQ VAS (HLGD, 63±17; non-neurological GD, 71±18; no GD, 82±14; p<0.001)”
Humans
BMJ neurology open
Depressive symptoms
upin humans1
1 study
Depressive symptoms
upin humans1
Higher-level gait disorders are associated with depressive symptoms in humans (GDS-15 HLGD, 3.9±3.4; non-neurological GD, 2.5±2.8; no GD, 1.4±2.0; p<0.05).
“HLGD had more depressive symptoms than non-neurological GD and no GD (GDS-15 HLGD, 3.9±3.4; non-neurological GD, 2.5±2.8; no GD, 1.4±2.0; p<0.05)”
Humans
BMJ neurology open